← Back to all earnings calls

TScan Therapeutics, Inc. Q2 FY2023 Earnings Call

TScan Therapeutics, Inc. (TCRX)

Earnings Call FY2023 Q2 Call date: 2023-08-10 Concluded

Share

Quarter scorecard

Revenue

$3.15M

-22.4% YoY

Diluted EPS

$-0.51

Net income

$

Documents & deck